JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M802239200 on July 17, 2008

J. Biol. Chem., Vol. 283, Issue 38, 26252-26262, September 19, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/38/26252    most recent
M802239200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Hewavitharana, T.
Right arrow Articles by Gill, D. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hewavitharana, T.
Right arrow Articles by Gill, D. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Location and Function of STIM1 in the Activation of Ca2+ Entry Signals*

Thamara Hewavitharana1, Xiaoxiang Deng, Youjun Wang, Michael F. Ritchie, Gannareddy V. Girish, Jonathan Soboloff2, and Donald L. Gill3

From the Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140

Store-operated channels (SOCs) mediate Ca2+ entry signals in response to endoplasmic reticulum (ER) Ca2+ depletion in most cells. STIM1 senses decreased ER luminal Ca2+ through its EF-hand Ca2+-binding motif and aggregates in near-plasma membrane (PM) ER junctions to activate PM Orai1, the functional SOC. STIM1 is also present in the PM, although its role there is unknown. STIM1-mediated coupling was examined using the stable EF20 HEK293 cell line expressing the STIM1-D76A/E87A EF-hand mutant (STIM1EF) deficient in Ca2+ binding. EF20 cells were viable despite constitutive Ca2+ entry, allowing study of SOC activation without depleting ER Ca2+. STIM1EF was exclusively in stable near-PM junctions, 3.5-fold larger than formed with STIM1WT. STIMEF-expressing cells had normal ER Ca2+ levels but substantially reduced ER Ca2+ leak. Expression of antiapoptotic Bcl-2 proteins (BCl-2, MCL-1, BCL-XL) were increased 2-fold in EF20 cells, probably reflecting survival of EF20 cells but not accounting for decreased ER Ca2+ leak. Surface biotinylation and streptavidin pull-down of cells expressing STIM1WT or STIM1EF revealed strong PM interactions of both proteins. Although surface expression of STIM1WT was clearly detectable, STIM1EF was undetectable at the cell surface. Thus, the Ca2+ binding-defective STIM1EF mutant exists exclusively in aggregates within near-PM junctions but, unlike STIM1WT, is not trafficked to the PM. Although not inserted in the PM, external application of a monoclonal anti-N-terminal STIM1 antibody blocked constitutive STIMEF-mediated Ca2+ entry, but only in cells expressing endogenous STIM1WT and not in DT40 STIM1 knock-out cells devoid of STIMWT. This suggests that PM-STIM1 may play a regulatory role in SOC activation.


Received for publication, March 20, 2008 , and in revised form, July 1, 2008.

* This work was supported in whole or in part, by National Institutes of Health Grants HL55426 (to D. L. G.) AI058173 (to D. L. G.). This work was also supported by the American Heart Association (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: Dept. of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104.

2 To whom correspondence may be addressed: Dept. of Biochemistry, Temple University School of Medicine, 3400 N. Broad St., Philadelphia PA 19140. Tel.: 215-707-6567; Fax: 215-707-7536; E-mail: soboloff{at}temple.edu.

3 To whom correspondence may be addressed: Dept. of Biochemistry, Temple University School of Medicine, 3400 N. Broad St., Philadelphia PA 19140. Tel.: 215-707-2501; Fax: 215-707-3263; E-mail: dgill{at}temple.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.